Literature DB >> 30465712

Facile generation of antibody heavy and light chain diversities for yeast surface display by Golden Gate Cloning.

Lukas Roth1, Julius Grzeschik1, Steffen C Hinz1, Stefan Becker2, Lars Toleikis2, Michael Busch3, Harald Kolmar1, Simon Krah2, Stefan Zielonka2.   

Abstract

Antibodies can be successfully engineered and isolated by yeast or phage display of combinatorial libraries. Still, generation of libraries comprising heavy chain as well as light chain diversities is a cumbersome process involving multiple steps. Within this study, we set out to compare the output of yeast display screening of antibody Fab libraries from immunized rodents that were generated by Golden Gate Cloning (GGC) with the conventional three-step method of individual heavy- and light-chain sub-library construction followed by chain combination via yeast mating (YM). We demonstrate that the GGC-based one-step process delivers libraries and antibodies from heavy- and light-chain diversities with similar quality to the traditional method while being significantly less complex and faster. Additionally, we show that this method can also be used to successfully screen and isolate chimeric chicken/human antibodies following avian immunization.

Entities:  

Keywords:  Golden Gate Cloning; antibody discovery; chimeric antibodies; gap repair cloning; human antibodies; yeast mating

Mesh:

Substances:

Year:  2019        PMID: 30465712     DOI: 10.1515/hsz-2018-0347

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  9 in total

1.  A One-Step Process for the Construction of Phage Display scFv and VHH Libraries.

Authors:  Carolin Sellmann; Lukas Pekar; Christina Bauer; Elke Ciesielski; Simon Krah; Stefan Becker; Lars Toleikis; Jonas Kügler; André Frenzel; Bernhard Valldorf; Michael Hust; Stefan Zielonka
Journal:  Mol Biotechnol       Date:  2020-04       Impact factor: 2.695

2.  A Generic Strategy to Generate Bifunctional Two-in-One Antibodies by Chicken Immunization.

Authors:  Julia Harwardt; Jan P Bogen; Stefania C Carrara; Michael Ulitzka; Julius Grzeschik; Björn Hock; Harald Kolmar
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786

3.  Streamlining the Transition From Yeast Surface Display of Antibody Fragment Immune Libraries to the Production as IgG Format in Mammalian Cells.

Authors:  David Fiebig; Jan P Bogen; Stefania C Carrara; Lukas Deweid; Stefan Zielonka; Julius Grzeschik; Björn Hock; Harald Kolmar
Journal:  Front Bioeng Biotechnol       Date:  2022-05-10

4.  Golden Gate assembly with a bi-directional promoter (GBid): A simple, scalable method for phage display Fab library creation.

Authors:  Karuppiah Chockalingam; Zeyu Peng; Christine N Vuong; Luc R Berghman; Zhilei Chen
Journal:  Sci Rep       Date:  2020-02-19       Impact factor: 4.379

5.  Prompting Fab Yeast Surface Display Efficiency by ER Retention and Molecular Chaperon Co-expression.

Authors:  Meng Mei; Junhong Li; Shengchen Wang; Ki Baek Lee; Brent L Iverson; Guimin Zhang; Xin Ge; Li Yi
Journal:  Front Bioeng Biotechnol       Date:  2019-11-26

6.  Expeditious Generation of Biparatopic Common Light Chain Antibodies via Chicken Immunization and Yeast Display Screening.

Authors:  Jan P Bogen; Stefania C Carrara; David Fiebig; Julius Grzeschik; Björn Hock; Harald Kolmar
Journal:  Front Immunol       Date:  2020-12-23       Impact factor: 7.561

7.  Grabbing the Bull by Both Horns: Bovine Ultralong CDR-H3 Paratopes Enable Engineering of 'Almost Natural' Common Light Chain Bispecific Antibodies Suitable For Effector Cell Redirection.

Authors:  Daniel Klewinghaus; Lukas Pekar; Paul Arras; Simon Krah; Bernhard Valldorf; Harald Kolmar; Stefan Zielonka
Journal:  Front Immunol       Date:  2022-01-11       Impact factor: 7.561

8.  Milking the Cow: Cattle-Derived Chimeric Ultralong CDR-H3 Antibodies and Their Engineered CDR-H3-Only Knobbody Counterparts Targeting Epidermal Growth Factor Receptor Elicit Potent NK Cell-Mediated Cytotoxicity.

Authors:  Lukas Pekar; Daniel Klewinghaus; Paul Arras; Stefania C Carrara; Julia Harwardt; Simon Krah; Desislava Yanakieva; Lars Toleikis; Vaughn V Smider; Harald Kolmar; Stefan Zielonka
Journal:  Front Immunol       Date:  2021-10-25       Impact factor: 7.561

Review 9.  Monoclonal Antibodies against SARS-CoV-2: Current Scenario and Future Perspectives.

Authors:  Eugenia Quiros-Roldan; Silvia Amadasi; Isabella Zanella; Melania Degli Antoni; Samuele Storti; Giorgio Tiecco; Francesco Castelli
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.